Ironwood Pharmaceuticals Profile

15.21
USD 0.34  2.19%
15.09Last Month High 17.32 
15.05Trading Day  High 15.62 

Exercise or conversion by Christopher Walsh of 10000 shares of Ironwood Pharmaceuticals subject to Rule 16b-3

Ironwood Pharmaceuticals Inc insider trading alert for exercise of employee stock option (right to buy) by Christopher Walsh, the corporate stakeholder, on December 13, 2017. This event was filed by Ironwood Pharmaceuticals with SEC on 2012-11-08. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Ironwood Pharmaceuticals Summary

Ironwood Pharmaceuticals Inc (IRWD) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 474 people. Ironwood Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 2.32 B. Ironwood Pharmaceuticals Inc has 135.39 M outstanding shares of which 17.74 M shares are currently shorted by private and institutional investors with about 11.73 trading days to cover. Ironwood Pharmace currently holds about 225.42 M in cash with (109.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.5.
Check Ironwood Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Wellington Management Group LlpCommon Shares18.9 M297.7 M
Fmr LlcCommon Shares18.5 M292.2 M
Linden Advisors LpDebt83.2 M99 M
View Ironwood Pharmaceuticals Diagnostics

Selected Ironwood Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Ironwood Pharmaceuticals Against Markets

Current Ratings  

Ironwood Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
3 
Chance of
< 42% 
Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameIronwood Pharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationMASSACHUSETTS, U.S.A
Business Address301 Binney Street, Cambridge, MA 02142, United States
ExchangeNASDAQ
CIK Number01446847.0
CUSIP46333X108
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.ironwoodpharma.com
Contact Number617 621 7722
CurrencyUSD - US Dollar

Recommendations

Ironwood Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
16.88Buy8Odds
Ironwood Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Ironwood Pharmaceuticals Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Ironwood Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.22May 8, 2017
Ironwood Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate